Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
akcea therapeutics
alnylam pharmaceuticals
archive
barry greene
biotech
blood pressure medication
boston
boston blog main
boston top stories
boston university
clinical trials
dan ollendorf
drugs
hereditary transthyretin amyloidosis
inotersen
john berk
life sciences
losartan
mary o'donnell
medical
national blog main
national top stories
new york blog main
new york top stories
patisiran
recall
recalls
regeneron pharmaceuticals
rna interference
safety
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
the amyloidosis foundation
the institute for clinical and economic review
vyndaqel
What
discovered
3
×
fda
cancer
administration
ago
alnylam
announced
approve
awaits
batches
biological
blood
causing
crossed
decades
decision
determine
diabetes
dis
drug
effort
expands
fingers
food
friday
historic
impurities
impurity
laboratory
medications
medicine
meds
metformin
multiple
ongoing
origins
patients
pharmaceuticals
popular
potentially
Language
unset
Current search:
discovered
×
fda
×
@slashgear.com
3 years ago
FDA warns popular diabetes drug has cancer risk, seeks multiple recalls
@bgr.com
4 years ago
FDA expands recall of blood pressure meds due to cancer-causing impurity
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision